Clinical trial reportJCO precision oncologyPublished
Pertuzumab Plus Trastuzumab in Patients With Lung Cancer With ERBB2 Mutation or Amplification: Results From the Targeted Agent and Profiling Utilization Registry Study
Regional connection
Verified An author affiliation on the Europe PMC record names Fox Chase Cancer Center, with Temple Health linked by the institution reference. Affiliation source
- Institutions
- Fox Chase Cancer Center, Temple Health
- County
- Philadelphia County
Publication record
- Type
- Clinical trial report
- Venue
- JCO precision oncology
- Published
- Topic
- Clinical care
- Subject terms
- Humans; Carcinoma, Non-Small-Cell Lung; Lung Neoplasms; Antineoplastic Agents; Mutation; Antibodies, Monoclonal, Humanized; Trastuzumab; Erb-b2 Receptor Tyrosine Kinases
- PubMed ID
- 37315265
- Added to directory
- Source checked